United Therapeutics Chairperson, CEO Rothblatt disposes of common shares worth $4.85 million
UTHR•Rothblatt exercises options and trust sells shares
United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42.
The trust then sold 9,500 shares in multiple trades at about USD 507.84 to USD 514.96 per share.
Trust holdings in common stock fell to 324,443 shares following the transactions.
Stock options held by a trust totaled 27,910 options after the exercise.
